Centrum Medyczne ENEL-MED (FRA:E19) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:E19 Centrum Medyczne ENEL-MED SA FRA:E19
76 GF Score
Price €4.18
GF Value €5.39
! 5 Warning Signs
View Full Analysis

What is Centrum Medyczne ENEL-MED FFO per Share?

FFO per Share only applies to REITs.

FRA:E19
76GF Score
Centrum Medyczne ENEL-MED SA FRA:E19
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Centrum Medyczne ENEL-MED (FRA:E19) Overvalued in 2026?

Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued. The current stock price of €4.18 is trading 22.4% below its estimated GF Value™ of €5.39.

Key valuation signals for FRA:E19:

  • FFO per Share:
  • GF Value™: €5.39 vs. price of €4.18 (22.4% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the FRA:E19 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Centrum Medyczne ENEL-MED Business Description

Other Exchanges ENE:Poland
Address ul. Slominskiego 19 lok. 524, Warsaw, POL, 00-195
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
76GF Score

Get the complete analysis for FRA:E19

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.18
Price
€5.39
GF Value